183.84
price up icon0.90%   +1.64
after-market  시간 외 거래:  185.00  1.16   +0.63%
loading

Resmed Inc (RMD) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
2.94%
1,196.98
1,162.80 1,102.32 1,122.06 1,116.90
Cost Of Revenue
2.26%
504.20
515.87 502.26 504.67 499.15
Gross Profit
7.09%
692.78
646.93 600.06 617.39 617.75
Operating Expenses
14.43%
318.20
371.84 311.06 342.12 317.08
Benefits Costs and Expenses
9.05%
821.56
903.35 830.13 845.25 827.52
Costs And Expenses
9.05%
821.56
903.35 830.13 845.25 827.52
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
36.17%
374.58
275.09 289.00 275.27 300.67
Net Interest Income/Expense
20.13%
-11.03
-13.80 -14.96 -14.94 -14.96
Nonoperating Income/Loss
105.35%
0.837
-15.64 -16.81 1.533 -11.29
Income/Loss Before Equity Method Investments
44.94%
374.98
258.71 276.09 279.03 289.56
Income/Loss From Equity Method Investments
40.46%
0.44
0.739 -3.895 -2.228 -0.183
Income/Loss From Continuing Operations Before Tax
44.70%
375.42
259.45 272.19 276.80 289.38
Income Tax Expense/Benefit
47.92%
74.93
50.65 52.77 47.14 56.88
Income/Loss From Continuing Operations After Tax
43.91%
300.49
208.80 219.42 229.66 232.50
Net Income/Loss
43.91%
300.49
208.80 219.42 229.66 232.50
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.12%
146.96
147.13 147.07 0.084 146.91
Diluted Average Shares
0.06%
147.45
147.54 147.49 0.055 147.40
Basic Earnings Per Share
43.66%
2.04
1.42 1.49 1.57 1.58
Diluted Earnings Per Share
43.66%
2.04
1.42 1.49 1.56 1.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
medical_instruments_supplies WST
$323.60
price down icon 2.24%
medical_instruments_supplies COO
$89.21
price down icon 0.67%
medical_instruments_supplies BAX
$33.96
price down icon 0.67%
$71.65
price down icon 1.15%
medical_instruments_supplies ALC
$89.80
price down icon 0.13%
자본화:     |  볼륨(24시간):